Ishwarlal Jialal

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Metabolic Syndrome

Top Venues

Journal of clinical medicine

Clinical medicine insights. Endocrinology and diabetes

Diabetes/metabolism research and reviews

Therapeutic advances in cardiovascular disease

This page only lists publications with an associated author ORCID identifier.

Publications

Beverley Adams-Huet, Ishwarlal Jialal
An Increasing Triglyceride-Glucose Index Is Associated with a Pro-Inflammatory and Pro-Oxidant Phenotype. Journal of clinical medicine 13 (13) (2024)
Beverley Adams-Huet, Ishwarlal Jialal
An Increasing Triglyceride-Glucose Index Is Associated with a Pro-Inflammatory and Pro-Oxidant Phenotype. Journal of clinical medicine 13 (13) (2024)
Ishwarlal Jialal, Verena Gounden
Novel and Promising Therapies for Diabetic Dyslipidemia to Mitigate Residual Cardiovascular Risk. Journal of clinical medicine 13 (16) (2024)
Ishwarlal Jialal, Verena Gounden
Novel and Promising Therapies for Diabetic Dyslipidemia to Mitigate Residual Cardiovascular Risk. Journal of clinical medicine 13 (16) (2024)
Ishwarlal Jialal, Samuel Olatunbosun
Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events. Journal of clinical medicine 12 (10) (2023)
Beverley Adams-Huet, Ishwarlal Jialal
Correlates of Insulin Resistance in Nascent Metabolic Syndrome. Clinical medicine insights. Endocrinology and diabetes 16 (2023)
Beverley Adams-Huet, Ishwarlal Jialal
Correlates of Insulin Resistance in Nascent Metabolic Syndrome. Clinical medicine insights. Endocrinology and diabetes 16 (2023)
Ishwarlal Jialal, Beverley Adams-Huet, Sridevi Devaraj
Increased Adipocyte Hypertrophy in Patients with Nascent Metabolic Syndrome. Journal of clinical medicine 12 (13) (2023)
Justine Cole, Rafael Zubirán, Anna Wolska, Ishwarlal Jialal, Alan T Remaley
Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change? Journal of clinical medicine 12 (17) (2023)
Beverley Adams-Huet, Ishwarlal Jialal
Correlates of Insulin Resistance in Nascent Metabolic Syndrome. Clinical medicine insights. Endocrinology and diabetes 16 (2023)
Ishwarlal Jialal, Naval Vikram
Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen? Therapeutic advances in cardiovascular disease 15 (2022)
Ishwarlal Jialal
Letter to the Editor From Jialal: "Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Syndrome: A Longitudinal Study". The Journal of clinical endocrinology and metabolism 107 (5) (2022)
Hiba Basheer, Beheshteh Nakhaee, Ishwarlal Jialal
Chylomicronemia Due to the Rare Hyperlipoproteinemia Type 3 Complicated by a Circulating Monoclonal Protein. Laboratory medicine 53 (5) (2022)
Ishwarlal Jialal, Ajay Sood
Letter to the Editor from Jialal and Sood: "New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation Using Specific Cortisol Assays". Journal of the Endocrine Society 5 (8) (2021)
Ishwarlal Jialal, Beverley Adams-Huet
The Ratios of Triglycerides and C-reactive protein to High density-lipoprotein -cholesterol as valid biochemical markers of the Nascent Metabolic Syndrome. Endocrine research 46 (4) (2021)
Ishwarlal Jialal, Ganesh Jialal, Beverley Adams-Huet
The platelet to high density lipoprotein -cholesterol ratio is a valid biomarker of nascent metabolic syndrome. Diabetes/metabolism research and reviews 37 (6) (2020)
Roma Pahwa, Anand Singh, Beverley Adams-Huet, Sridevi Devaraj, Ishwarlal Jialal
Increased inflammasome activity in subcutaneous adipose tissue of patients with metabolic syndrome. Diabetes/metabolism research and reviews 37 (3) (2020)
Ishwarlal Jialal, Sridevi Devaraj
AHA/ACC/Multisociety Cholesterol Guidelines: highlights. Therapeutic advances in cardiovascular disease 13 (2020)
Ishwarlal Jialal, Roma Pahwa
Fetuin-A is also an adipokine. Lipids in health and disease 18 (1) (2019)
Beverley Adams-Huet, Ishwarlal Jialal
The neutrophil count is superior to the neutrophil/lymphocyte ratio as a biomarker of inflammation in nascent metabolic syndrome. Annals of clinical biochemistry 56 (6) (2019)